137 related articles for article (PubMed ID: 27511884)
21. Nonspecific immunotherapy with intratumoral lipopolysaccharide and zymosan A but not GM-CSF leads to an effective anti-tumor response in subcutaneous RG-2 gliomas.
Mariani CL; Rajon D; Bova FJ; Streit WJ
J Neurooncol; 2007 Dec; 85(3):231-40. PubMed ID: 17568998
[TBL] [Abstract][Full Text] [Related]
22. Toll-like receptor 4-induced inflammatory responses contribute to the tumor-associated macrophages formation and infiltration in patients with diffuse large B-cell lymphoma.
Wang X; Li X; Zhang X; Zang L; Yang H; Zhao W; Zhao H; Li Q; Xia B; Yu Y; Wang Y; Zhao Z; Zhang Y
Ann Diagn Pathol; 2015 Aug; 19(4):232-8. PubMed ID: 26071054
[TBL] [Abstract][Full Text] [Related]
23. Toll-like receptor (TLR) 2 agonists ameliorate indomethacin-induced murine ileitis by suppressing the TLR4 signaling.
Narimatsu K; Higashiyama M; Kurihara C; Takajo T; Maruta K; Yasutake Y; Sato H; Okada Y; Watanabe C; Komoto S; Tomita K; Nagao S; Miura S; Hokari R
J Gastroenterol Hepatol; 2015 Nov; 30(11):1610-7. PubMed ID: 25867219
[TBL] [Abstract][Full Text] [Related]
24. Saikosaponin a inhibits LPS-induced inflammatory response by inducing liver X receptor alpha activation in primary mouse macrophages.
Wei Z; Wang J; Shi M; Liu W; Yang Z; Fu Y
Oncotarget; 2016 Aug; 7(31):48995-49007. PubMed ID: 27285988
[TBL] [Abstract][Full Text] [Related]
25. Subdiaphragmatic vagotomy promotes tumor growth and reduces survival via TNFα in a murine pancreatic cancer model.
Partecke LI; Käding A; Trung DN; Diedrich S; Sendler M; Weiss F; Kühn JP; Mayerle J; Beyer K; von Bernstorff W; Heidecke CD; Keßler W
Oncotarget; 2017 Apr; 8(14):22501-22512. PubMed ID: 28160574
[TBL] [Abstract][Full Text] [Related]
26. Lipoteichoic acid of Streptococcus mutans interacts with Toll-like receptor 2 through the lipid moiety for induction of inflammatory mediators in murine macrophages.
Hong SW; Baik JE; Kang SS; Yun CH; Seo DG; Han SH
Mol Immunol; 2014 Feb; 57(2):284-91. PubMed ID: 24216318
[TBL] [Abstract][Full Text] [Related]
27. Stable transduction of bovine TLR4 and bovine MD-2 into LPS-nonresponsive cells and soluble CD14 promote the ability to respond to LPS.
Sauter KS; Brcic M; Franchini M; Jungi TW
Vet Immunol Immunopathol; 2007 Jul; 118(1-2):92-104. PubMed ID: 17559944
[TBL] [Abstract][Full Text] [Related]
28. Toll-like receptor 2 mediates inflammatory cytokine induction but not sensitization for liver injury by Propioni- bacterium acnes.
Romics L; Dolganiuc A; Velayudham A; Kodys K; Mandrekar P; Golenbock D; Kurt-Jones E; Szabo G
J Leukoc Biol; 2005 Dec; 78(6):1255-64. PubMed ID: 16204620
[TBL] [Abstract][Full Text] [Related]
29. Low doses of gamma irradiation potentially modifies immunosuppressive tumor microenvironment by retuning tumor-associated macrophages: lesson from insulinoma.
Prakash H; Klug F; Nadella V; Mazumdar V; Schmitz-Winnenthal H; Umansky L
Carcinogenesis; 2016 Mar; 37(3):301-313. PubMed ID: 26785731
[TBL] [Abstract][Full Text] [Related]
30. Toll-Like Receptor Ligands and Interferon-γ Synergize for Induction of Antitumor M1 Macrophages.
Müller E; Christopoulos PF; Halder S; Lunde A; Beraki K; Speth M; Øynebråten I; Corthay A
Front Immunol; 2017; 8():1383. PubMed ID: 29123526
[TBL] [Abstract][Full Text] [Related]
31. Targeting tumor-associated macrophages to combat pancreatic cancer.
Cui R; Yue W; Lattime EC; Stein MN; Xu Q; Tan XL
Oncotarget; 2016 Aug; 7(31):50735-50754. PubMed ID: 27191744
[TBL] [Abstract][Full Text] [Related]
32. Candida albicans-derived mannoproteins activate NF-κB in reporter cells expressing TLR4, MD2 and CD14.
Ness T; Abdallah M; Adams J; Alvarado C; Gunn E; House B; Lamb J; Macguire J; Norris E; Robinson R; Sapp M; Sharma J; Garner R
PLoS One; 2017; 12(12):e0189939. PubMed ID: 29281684
[TBL] [Abstract][Full Text] [Related]
33. Elevated CD14 (Cluster of Differentiation 14) and Toll-Like Receptor (TLR) 4 Signaling Deteriorate Periapical Inflammation in TLR2 Deficient Mice.
Rider D; Furusho H; Xu S; Trachtenberg AJ; Kuo WP; Hirai K; Susa M; Bahammam L; Stashenko P; Fujimura A; Sasaki H
Anat Rec (Hoboken); 2016 Sep; 299(9):1281-92. PubMed ID: 27314637
[TBL] [Abstract][Full Text] [Related]
34. Signaling crosstalk during sequential TLR4 and TLR9 activation amplifies the inflammatory response of mouse macrophages.
De Nardo D; De Nardo CM; Nguyen T; Hamilton JA; Scholz GM
J Immunol; 2009 Dec; 183(12):8110-8. PubMed ID: 19923461
[TBL] [Abstract][Full Text] [Related]
35. TAK-242 selectively suppresses Toll-like receptor 4-signaling mediated by the intracellular domain.
Kawamoto T; Ii M; Kitazaki T; Iizawa Y; Kimura H
Eur J Pharmacol; 2008 Apr; 584(1):40-8. PubMed ID: 18299127
[TBL] [Abstract][Full Text] [Related]
36. Tumor-associated macrophage-derived CCL20 enhances the growth and metastasis of pancreatic cancer.
Liu B; Jia Y; Ma J; Wu S; Jiang H; Cao Y; Sun X; Yin X; Yan S; Shang M; Mao A
Acta Biochim Biophys Sin (Shanghai); 2016 Dec; 48(12):1067-1074. PubMed ID: 27797715
[TBL] [Abstract][Full Text] [Related]
37. Type I, but not type II, interferon is critical in liver injury induced after ischemia and reperfusion.
Zhai Y; Qiao B; Gao F; Shen X; Vardanian A; Busuttil RW; Kupiec-Weglinski JW
Hepatology; 2008 Jan; 47(1):199-206. PubMed ID: 17935177
[TBL] [Abstract][Full Text] [Related]
38. Hepcidin-ferroportin axis controls toll-like receptor 4 dependent macrophage inflammatory responses in human atherosclerotic plaques.
Habib A; Polavarapu R; Karmali V; Guo L; Van Dam R; Cheng Q; Akahori H; Saeed O; Nakano M; Pachura K; Hong CC; Shin E; Kolodgie F; Virmani R; Finn AV
Atherosclerosis; 2015 Aug; 241(2):692-700. PubMed ID: 26125411
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of tumor angiogenesis by interferon-γ by suppression of tumor-associated macrophage differentiation.
Sun T; Yang Y; Luo X; Cheng Y; Zhang M; Wang K; Ge C
Oncol Res; 2014; 21(5):227-35. PubMed ID: 24854099
[TBL] [Abstract][Full Text] [Related]
40. The effect of the accessory proteins, soluble CD14 and lipopolysaccharide-binding protein on Toll-like receptor 4 activity in human monocytes and adipocytes.
Pahwa R; Devaraj S; Jialal I
Int J Obes (Lond); 2016 Jun; 40(6):907-11. PubMed ID: 26880233
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
